Serum cholesterol and cancer.
Serum cholesterol and cancer.
复制标题
血清胆固醇与癌症。
作者:
M. Law
Many prospective epidemiological studies have examined the relationship between serum cholesterol and ischaemic heart disease. The discovery of an association of low serum cholesterol with cancer in these studies was unexpected (Rose et al., 1974), but many of the studies have confirmed it. An explanation emerged with the recognition that pre-clinical cancer lowers serum cholesterol (Rose & Shipley, 1980; Cambien et al.. 1980), probably due to increased low-densitylipoprotein (LDL) receptor activity in malignant cells (Vitols et al., 1985). It has been uncertain however whether this short term effect entirely accounts for the association of low serum cholesterol with cancer: there is conflicting evidence as to the presence of an additional long term association not explained by pre-clinical cancer. A recent analysis of all the published prospective studies (Law & Thompson, 1991) showed that there is a long-term effect. When the data from each published study were expressed in the same way (as the mean case-control serum cholesterol difference) and adequate allowance was made for the pre-clinical effect by omitting the early cancers (those presenting in the first two years in incidence studies or the first 5 years in mortality studies), the mean serum cholesterol was significantly lower in persons who developed cancer than in those who did not (P<0.001). The long term effect is small however, equivalent on average to about a 15% increased cancer incidence in the lowest cholesterol quintile group (the short term association is much greater). There is also pronounced variation between studies, the effect being large in some studies but absent in others, confirmed by a measure of heterogeneity that was also statistically significant (P = 0.01). This association of low serum cholesterol with cancer is not seen in international comparisons. Low cholesterol countries like Japan and China, Greece and Spain, have lower rates of heart disease than northern Europe and North America, but their rates of cancer are no higher. The Seven Countries Study has confirmed a long-term association of low cholesterol with both cancer of all sites and lung cancer within the countries, but has shown no association between the seven countries (Keys et al., 1985). Variation in serum cholesterol between countries is determined almost entirely by dietary differences, whereas variation between individuals within a country has an important genetic component. The absence of an international association of low cholesterol with cancer therefore suggests that low dietary fat does not predispose to cancer, and indeed both animal studies and epidemiological evidence indicate that if anything the opposite is the case, high dietary fat being associated with increased cancer risk (Kinlen, 1983; Carroll et al.. 1986; Prentice & Sheppard. 1990). The long term association of low cholesterol with cancer in individuals might therefore suggest a genetic linkage between a gene associated with low cholesterol and another that predisposes to cancer. It seems more likely however that the
DOI:
--
发表时间:
1987
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
Wynder,EL;Hebert,JR;Kabat,GC
通讯作者:
Kabat,GC
影响因子:
5
作者:
Freedman,DS;Srinivasan,SR;Shear,CL;Hunter,SM;Croft,JB;Webber,LS;Berenson,GS
通讯作者:
Berenson,GS